CUHK scientists found HIV drug Maraviroc can help to slow and mitigate ageing for sarcopenia. Clinical trials on elderly patients planned next year may offer breakthrough treatment.

CUHK scientists joined China’s Antarctic expedition, researching climate impacts like melting, greening, and pollution. Despite harsh conditions, they valued collaboration, international exchange, and personal discoveries, stressing the need for continuous long-term climate monitoring.

CUHK Professor develops a series of wearable robotics for elderly care and stroke rehabilitation, targeting Hong Kong and China’s silver economy with soft joint supports and brain-computer interface rehabilitation devices to advance patients’ rehabilitation progress..

CUHK researchers enhanced traditional Yu-Ping-Feng formula with added herbs to treat hay fever. Clinical trials showed 40% patient improvement, offering an alternative therapy by boosting immunity and long-term resistance.

CUHK Professor studied human-induced earthquakes in Sichuan shale gas fields, which provides new insights into the triggering mechanisms of destructive earthquakes and disaster relief strategies. It helps assess risks and improve prevention.

CUHK’s faculty of medicine said it is the first in the world to make use of a self-built robotic system to help doctors remove a tumour in the bladder in one piece, which can also lower the chance of a bladder cancer recurrence.

A CUHK-led multinational study proved that a new drug (D3S-001) developed by a mainland Chinese biotechnology company is effective in combating three types of cancer that currently have limited treatment options.

In this episode (begins from 39:09), main architect of CUHK Art Museum’s new Lo Kwee Seong Pavilion explains the architectural gist, while the museum’s Director Professor Josh Yiu introduces its inaugural exhibition.

In an exclusive interview, Professor Dennis Lo, Vice-Chancellor and President of CUHK, shares that increasing geopolitics uncertainties have benefited the University in attracting talent, and CUHK had hired over 150 academics from more than 10 places since 2023.

A research team at CUHK discovered a new underlying mechanism and possible therapeutic target for Huntington’s disease, a rare, incurable illness that can cause twitching movements and cognitive decline.

CUHK-led researchers completed the first gapless genome of Hong Kong’s iconic Bauhinia, confirming its hybrid origin from B. purpurea and B. variegata, uncovering genetic mechanisms behind its traits, resilience, and hybrid vigor.

An international research team led by CUHK has achieved a breakthrough in the field of medical microrobots by developing the world’s first antibiofilm liquid-bodied magnetic-controlled robot, a new solution to combat biofilm infections.